Cite

HARVARD Citation

    Astarita, A. et al. (n.d.). Cardiovascular risk assessment in multiple myeloma patients undergoing carfilzomib therapy: a new risk prediction model for cardiovascular adverse events. European heart journal. p. . [Online]. 
  
Back to record